Academic and industry researchers, clinicians, regulatory officers, bioinformatics experts, biostatisticians, and scientists from imaging, diagnostic, and pharmaceutical industries, who are interested in opening a dialogue among disciplines, improving the use of Integrated Biomarkers to support clinical decision-making and to improve patient assessment.